Evidence map›Paper›PMID 24973090›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2014

Sialic acid rescues repurified lipopolysaccharide-induced acute renal failure via inhibiting TLR4/PKC/gp91-mediated endoplasmic reticulum stress, apoptosis, autophagy, and pyroptosis signaling.

Chih-Ching Yang, Chien-An Yao, Jyh-Chin Yang, Chiang-Ting Chien

Open access · greenAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. The Role of Pyroptosis in the Pathogenesis of Kidney Diseases.Kidney diseases (Basel, Switzerland) · 2023
    Review
  8. Review
  9. Recent advances onSynthetic and systems biotechnology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Regulated cell death in cisplatin-induced AKI: relevance ofAmerican journal of physiology. Renal physiology · 2021
    Article
  20. Pyroptosis: A New Frontier in Kidney Diseases.Oxidative medicine and cellular longevity · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Chih-Ching YangDepartment of Internal Medicine, National Yang-Ming University, Taipei 11221, Taiwan Department of Family Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
Chien-An YaoNational Taiwan University Hospital and College of Medicine, Taipei 10016, Taiwan.
Jyh-Chin YangDepartment of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan ctchien@ntnu.edu.tw.
Chiang-Ting ChienDepartment of Planning, Ministry of Health and Welfare, Executive Yuan, Taipei 11558, Taiwan ctchien@ntnu.edu.tw.
Ministry of Health and Welfare · KRNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopolysaccharides (LPS) through Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4) activation induce systemic inflammation where oxidative damage plays a key role in multiple organ failure. Because of the neutralization of LPS toxicity by sialic acid (SA), we determined its effect and mechanisms on repurified LPS (rLPS)-evoked acute renal failure. We assessed the effect of intravenous SA (10 mg/kg body weight) on rLPS-induced renal injury in female Wistar rats by evaluating blood and kidney reactive oxygen species (ROS) responses, renal and systemic hemodynamics, renal function, histopathology, and molecular mechanisms. SA can interact with rLPS through a high binding affinity. rLPS dose- and time-dependently reduced arterial blood pressure, renal microcirculation and blood flow, and increased vascular resistance in the rats. rLPS enhanced monocyte/macrophage (ED-1) infiltration and ROS production and impaired kidneys by triggering p-IRE1α/p-JNK/CHOP/GRP78/ATF4-mediated endoplasmic reticulum (ER) stress, Bax/PARP-mediated apoptosis, Beclin-1/Atg5-Atg12/LC3-II-mediated autophagy, and caspase 1/IL-1β-mediated pyroptosis in the kidneys. SA treatment at 30 min, but not 60 min after rLPS stimulation, gp91 siRNA and protein kinase C-α (PKC) inhibitor efficiently rescued rLPS-induced acute renal failure via inhibition of TLR4/PKC/NADPH oxidase gp91-mediated ER stress, apoptosis, autophagy and pyroptosis in renal proximal tubular cells, and rat kidneys. In response to rLPS or IFNγ, the enhanced Atg5, FADD, LC3-II, and PARP expression can be inhibited by Atg5 siRNA. Albumin (10 mg/kg body weight) did not rescue rLPS-induced injury. In conclusion, early treatment (within 30 min) of SA attenuates rLPS-induced renal failure via the reduction in LPS toxicity and subsequently inhibiting rLPS-activated TLR4/PKC/gp91/ER stress/apoptosis/autophagy/pyroptosis signaling.

Indexed as

Acute Kidney InjuryAnimalsApoptosisAutophagyAutophagy-Related Protein 5Blotting, WesternEndoplasmic Reticulum StressEndotoxinsFemaleInjections, IntravenousMembrane GlycoproteinsN-Acetylneuraminic AcidNADPH Oxidase 2NADPH OxidasesProtein Kinase C-alphaProteinsAtg5 protein, ratAutophagy-Related Protein 5Cybb protein, ratendotoxin, Escherichia coliEndotoxinsMembrane GlycoproteinsN-Acetylneuraminic AcidNADPH Oxidase 2NADPH OxidasesProtein Kinase C-alphaProteinsReactive Oxygen SpeciesRNA, Small InterferingTlr4 protein, ratToll-Like Receptor 4apoptosisautophagylipopolysaccharidepyroptosisreactive oxygen speciessialic acidtoll-like receptors

Identifiers

PMID24973090
PMCPMC4833108
OpenAlexW2054877805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.